Moreover, higher levels of MEG3 were associated with enhanced overall survival (OS), relapse-free survival (RFS), distant metastasis-free survival (DMFS), and disease-specific survival (DSS) in breast cancer [34]. Here, MEG3 is linked to breast cancer.